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Pre-conceptional  supplementation  of  folic  acid 
is well known to reduce the incidence of spina 
bifida.  But  Athena  is  frequently  perplexed  to 
see this anomaly occurring despite folate sup-
plementation. In a largest Canadian study, De 
Wal et al [1] screened 1.9 million live births to 
study the effect of mass fortification. On com-
paring  pre  and  post  fortification  periods  they 
noted  only  46%  reduction  in  the  incidence  of 
neural tube defects (NTD). What happens to the 
remaining 54%? Why do they defy “folic acid” 
logics?  Recently several publications have shed 
more light on this intriguing question. 
Researchers at the University of Tokyo [2] stud-
ied  serum  level  of  folic  acid  in  254  pregnant 
women  and  correlated  it  with  dietary  habits 
and total folate intake per day. They found that 
serum folate was significantly lower in women 
taking green tea and oolong tea than those tak-
ing black tea. This effect was noted even at 100 
to 130 ml of tea intake per day. Reduced bioa-
vailability  of  folate  in  these  women  has  been 
attributed to interaction of tea catechin (tannin) 
and  dietary  folate.  Epigallo  Catechin  Gallate 
(EGCG),  a  tea  catechin,  is  found  to  inhibit 
Dihydroxy  Folate  Reductase.  This  enzyme  is 
essential  to  convert  dietary  folic  acid  into 
Tetrahydroxy  Folate  which  is  the  active  form. 
Even  if  a  pregnant  woman  takes  adequate 
folate supplementation, concurrent ingestion of 
tea will reduce its bioavailability and results in 
deficiency  state.  Another  team  of  Boston  epi-
demiologists  [3]  independently  verified  these 
findings  from  clinical  point  of  view.  In  that 
study, they compared mothers of 518 spina bi-
fida cases with 6424 controls for tea consump-
tion. Among women with folic acid intake great-
er  than  400  µg per  day,  consumption of  3 or 
more cups of tea per day significantly increased 
the risk of fetal spina bifida. Athena considers 
it prudent to advise newlywed women to avoid 
tea. In India, tea is popular in some northern 
states  while  coffee  is  preferred  in  southern 
states. A comparison of the incidence of NTD in 
these  states  would probably  be  an  interesting 
study.       
Emejulu  and  co-workers  [4]  from  south-east 
Nigeria were intrigued by the high incidence of 
spina bifida in areas endemic of malaria. What 
could  the  relationship  between  plasmodium 
and  neural  tube?  Further  inquiry  suggested 
that  antimalarial  drugs  rather  than  plasmodi-
um  could  be  the  culprit.  All  the  41  mothers 
who  had  anomalous  children  had  taken  anti-
malarial  drugs  during  first  trimester. 
Chloroquine  and  other  antimalarial  drugs  act 
by  blocking  folate  metabolism  of  plasmodium. 
Analogically they can also block folate metabo-
lism of pregnant women. Thus concurrent ad-
ministration of antimalarial drugs reduces the 
bio-utilization  of  folates  thereby  increase  the 
risk of malformations. Athena considers this as 
an important discovery with direct implication 
to  South-east  Asian  and  African  countries.  In 
the  background  of  this  new  study  she  ques-
tions  the prudence of  Mass  Drug Administra-
tion  under  National  Malaria  Eradication  Pro-
gram (NMEP). 
A  recent  study  from  Texas  [5]  indicates  that 
spina  bifida  can  occur  despite  folate  supple-
mentation if target cells are deprived of the vit-
amin. These researchers have identified 3 types 
of folate receptors (FOLR1, FOLR2, FOLR3) in 
cell  membranes.  These  receptors  are essential 
to maintain critical levels of intracellular folate 
by  unidirectional  transport  and  cytoplasmic 
release of folic acid. Embryos carrying defective 
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genes  codifying  these  receptor  proteins  are 
more  likely  to  develop  meningomyelocele  de-
spite maternal supplementation of folates. Tex-
as  researchers  tested  this  hypothesis  in  329 
affected  child-parent  trios,  281  affected  child-
parent  duos  and  92  controls.  They  identified 
several  alleles  of  the  receptor  genes  that  are 
associated  with  increased  risk  of 
meningomyelocele.  Athena  is  curiously  inter-
ested  to  know  how  the  findings  of  this  basic 
research can be translated into clinical use.  
Folic acid prevents NTD by taking part in the 
repair of damaged DNA of neural crest cells. It 
is then logical that a newborn may develop spi-
na bifida despite maternal folate supplements if 
the  collateral  damage  of  DNA  exceeds  the  re-
parative process. Oxidative stress and free radi-
cals produced thereof are well known to cause 
DNA damage. Organic solvents which are com-
monly used in inks,  pesticides,  fuels, cosmet-
ics,  and  dyes  are  known  to  cause  oxidative 
stress. Therefore, the US National Birth Defects 
Prevention  Study  Group  [6]  investigated  the 
relationship between NTD and organic solvents. 
The analysis included 511 mothers of NTD cas-
es and 2972 controls. Women were enrolled if 
they had been occupationally exposed to organ-
ic solvents for at least 30 days from 1 month 
preceding  the  estimated  date  of  conception 
through the end of first trimester. Nearly 14% 
of affected mothers had been exposed to organ-
ic solvents as against only 8% of control group. 
Among the various types of solvents, Chlorinat-
ed  chemicals  such  as  carbon  tetrachloride, 
chloroform  and  trichloroethylene  carried  a 
higher risk of NTD than aromatic solvents such 
as Benzene, Xylene and Toluene. Interestingly, 
75.6% of affected mothers had received precon-
ception folate supplements!   
Analogous to organic solvents hydrocarbon ex-
haust of automobiles can also cause oxidative 
stress.  Diesel  exhaust  particles  (DEP)  are  fre-
quently less than 0.1 micron in size. Owing to 
this extremely small size they enter circulation 
if inhaled and easily cross blood-brain barrier 
and placental barrier. Simsek et al [7] have re-
cently studied the teratogenic effect of DEP in 
chick embryo model. They injected DEP of 10, 
50,  100  and  200  µm  sizes  into  30-hour-old 
chicks.  Examination  of  the  embryos  at  72 
hours of incubation revealed that the group ex-
posed  to  DEP  was  at  high  risk  of  malfor-
mations.  NTD  was  noted  in  18%  of  embryos 
exposed  to  DEP  while  in  none  of  the  control 
group.  The  risk  of  malformation  was  higher 
with increasing particle size. About 40% of em-
bryos developed NTD when exposed to 200 µm 
DEP  while  the  incidence  was  as  low  as  8  to 
13% for smaller size particles. It is to be seen if 
this  DEP  induced  NTD  can  be  prevented  by 
folate supplements. Athena considers this as a 
seminal work in view of ubiquitous air pollution 
of the modern world. She is interested to know 
if  the  incidence  of  NTD  differs  between  rural 
and  urban  populations  as  the  latter  is  more 
exposed to DEP. The common denominator of 
teratogenicity of  organic solvents  or  hydrocar-
bons is the DNA damage induced by oxidative 
stress and free radicals. Neural crest cells are 
more  vulnerable  for  oxidative  stress  not  only 
because  of  their  high  metabolic  demand  but 
also because of paucity of endogenous scaven-
gers such as Vitamin C. Athena wonders if we 
should  supplement  Vitamin  C  along  with 
folates  to  prevent  DNA  damage  that  bypasses 
folate mechanism.   
Athena has seen high incidence of NTD follow-
ing  threatened  abortions  and  assisted  repro-
duction  techniques  such  as  in-vitro  fertiliza-
tion. It is attributed to high doses of progester-
one  used  to  avoid  fetal  loss  in  these  clinical 
scenarios.  Iqbal  et  al  [8]  studied  the  effect  of 
high dose progesterone on the development of 
neural  tube  using  chick  embryo  model.  They 
found NTD in 75% of the eggs treated with high 
dose progesterone while none of control group 
embryos  developed  this  malformation.  When 
they supplemented 5 µg of folic acid the inci-
dence of NTD dropped to 58%. It appears that 
both  progesterone  and  folic  acid  mutually 
blocking each other by competing for the same 
receptor. The common receptor is identified as 
GABA-A (Gamma Amino Butyric Acid receptor 
A).  GABA  is  well  known  to  be  an  important 
neurochemical. GABA-A agonists are known to 
increase the risk of NTD. Progesterone acts as 
GABA-A agonist while folic acid acts as antago-
nist  at  the  receptor.  By  competitive  binding 
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and efflux of folic acid. Thus, high levels of ma-
ternal progesterone may produce fetal deficien-
cy  of  folates  despite  supplementations.  Cur-
rently 400 µg per day is the recommended dose 
of folic acid supplementation. It remains to be 
seen if increasing the dosage of folate supple-
ment  would  oppose  the  teratogenic  effect  of 
progesterone by competitive receptor blocking.  
Athena now realizes that there are many a slip 
between cup and the lip. Taking folate supple-
ments  is  not  sufficient  to  prevent  NTD.  The 
process  requires  understanding  of  a  complex 
sequence  involving  adequate  absorption,  opti-
mal bioavailability, drug interactions, presence 
of  appropriate  receptors,  competitive  receptor 
blocking  and  degree  of  collateral  damage  to 
DNA. 
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